use of protein-coupled receptor agonists, but in the treatment of metabolic syndrome, its components and its complications

摘要

USE OF PROTEIN G-COUPLED RECEPTOR AGONISTS, BUT IN THE TREATMENT OF METABOLIC SYNDROME, COMPONENTS, AND THEIR COMPLICATIONS. The present invention is characterized by the use of protein G-coupled receptor agonists, but as a mechanism of control, prevention and treatment of triglyceride, cholesterol and glucose body levels, as well as arterial hypertension and possible body weight increase, characteristic of the metabolic syndrome and its complications. Another feature of the invention is the use of protein G-coupled receptor agonists, But, including the Angiotensin- (1-7) peptide and its analogs, agonists, peptides or non-peptides as modulators of insulin resistance and insulin intolerance. glucose and the prevention and treatment of related changes. The invention claims the use of protein G-coupled receptor agonists, MAS, formulated with pharmaceutically and pharmacologically acceptable excipients or carriers, and protein G-coupled receptor agonists, but including the Angiotensin- (1-7) peptide and analogs thereof. , agonists, peptides or non-peptides as modulators of the metabolic syndrome, its diseases and their complications.